Retraction Note: E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage (Oncogene, (2000), 19, 4, (592-598), 10.1038/sj.onc.1203339);E6 proteins from diverse cutaneons HPV types inhibit apoptosis in response to UV damage

Oncogene

Volumn 19, Issue 4, 2000, Pages 592-598

  Jackson, Sarah ^a   Storey, Alan ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Apoptosis; HPV; Skin; UV

Indexed keywords

PROTEIN P53; VIRUS PROTEIN;

APOPTOSIS; CONTROLLED STUDY; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SKIN CANCER; SKIN DEFECT; ULTRAVIOLET IRRADIATION; WART VIRUS;

EID: 0034719466     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-023-02693-8     Document Type: Erratum

References (44)

1. Amundsen SA, Myers TG and Fornace AJ. (1998). Oncogene, 17, 3287-3299.
2. Berkhout RJM, Tieben LM, Smits HL, Bavinck JNB, Vermeer BJ and ter Schegget J. (1995). J. Clin. Micro., 33, 690-695.
3. Campbell C, Quinn AG, Angus B, Farr PM and Rees JL. (1993). Can. Res., 53, 2697-2699.
4. Crook T, Wrede D and Vousden KH. (1991). Oncogene, 6, 873-875.
5. de Jong-Tieben LM, Berkhout JM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ and ter Scheget J. (1995). J. Invest. Dermatol., 105, 367-371.
6. Delius H, Saegling B, Bergmann K, Shamanin V and de Villiers E-M. (1998). Virology, 240, 359-365.
7. Dyson N, Howley PM, Münger K and Harlow E. (1989). Science, 243, 934-936.
8. Elbel M, Carl S, Spaderna S and Iftner T. (1997). Virology, 239, 132-149.
9. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
10. Favre M, Obalek S, Jablonska S and Orth G. (1989). J. Virol., 63, 4909.F.
11. Grossman D and Leffell DJ. (1997). Arch. Derm., 133, 1263-1270.
12. Hall PA, McKee PH, Menage HD, Dover R and Lane DP. (1993). Oncogene, 8, 203-207.
13. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
14. Hopfl R, Bens G, Wieland U, Petter A, Zelger B, Fritsch P and Pfister H. (1997). J. Invest. Derm., 108, 53-56.
15. Huibregste JM, Scheffner M and Howley PM. (1991). EMBO J., 10, 4129-4135.
16. Huibregste JM, Scheffner M and Howley PM. (1993). Mol. Cell. Biol., 13, 4918-4927.
17. Jablonska S. (1990). Papillomaviruses and human cancer. Pfister H (ed.). Boca Raton, FL, pp. 46-71.
18. Jablonska S, Dabrowski J and Jakubowicz K. (1972). Can. Res., 32, 583-589.
19. Lane D and Crawford L. (1979). Nature, 278, 261-263.
20. Majewski S and Jablonska S. (1995). Arch. Dermatol., 131, 1312-1318.
21. Obalek S, Favre M, Szymanczyk J, Misiwiecz J, Jablonska S and Orth G. (1992). J. Invest. Dermatol., 98, 936-941.
22. Okan I, Wang Y, Chen F, Hu L-F, Imreh S, Klein G and Wiman KG. (1995). Oncogene, 11, 1027-1031.
23. Oltvai ZN, Milliman CL and Korsmeyer SJ. (1993). Cell, 74, 609-619.
24. Orth G. (1987). The Papovaviridae. Salzman NP and Howley PM (eds). Plenum Press: New York, pp. 189-243.
25. Orth G, Jablonska S, Jarzabek-Chorzelska M, Obalek S, Rzesa G, Favre M and Croissant O. (1979). Cancer Res., 39, 1074-1082.
26. Petrocelli T, Poon R, Drucker DJ, Slingerland JM and Rosen CF. (1996). Oncogene, 12, 1387-1396.
27. Polyak K, Xia Y, Zweler JL, Kinzler KW and Vogelstein B. (1997). Nature, 389, 300-305.
28. Proby C, Storey A, McGregor J and Leigh I. (1996). Papillomavirus Report, 7, 53-60.
29. Purdie KJ, Sexton CJ, Proby CM, Glover MT, Williams AT, Stables JN and Leigh IM. (1993). Cancer Res., 53, 5328-5333.
30. Sarnow P, Ho YS, Williams J and Levine AJ. (1982). Cell, 28, 387-394.
31. Scheffner M, Huibregste JM and Howley PM. (1994). Proc. Natl. Acad. Sci. USA, 91, 8797-8801.
32. Scheffner M, Huibregste JM, Vierstra RD and Howley PM. (1993). Cell, 75, 495-505.
33. Scheffner M, Münger K, Byrne JC and Howley PM. (1991). Proc. Natl. Acad. Sci. USA, 88, 5523-5527.
34. Scheffner M, Nuber U and Huibregste JM. (1995). Nature, 373, 81-83.
35. Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, zur Hausen H and de Villiers E-M. (1994). Cancer Res., 54, 4610-4613.
36. Shamanin V, zur Hausen H, Lavergne D, Proby C, Leigh IM, Neumann C, Hamm H, Goos M, Haustein U-F, Jun EG, Plewig G, Wolff H and de Villiers E-M. (1996). J. Natl. Can. Inst., 88, 802-811.
37. Smith ML, Chen L-T, Zhan Q, O'Connor PM and Fornace AJ. (1995). Oncogene, 10, 1053-1059.
38. Steger G and Pfister H. (1992). Arch. Virol., 125, 355-360.
39. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L. (1998). Nature, 393, 229-234.
40. Surentheran T, Harwood CA, Spink PJ, Sinclair AL, Leigh IM, Proby CM, McGregor JM and Breuer J. (1998). J. Clin. Path., 51, 606-610.
41. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.
42. Wyllie AH. (1980). Nature, 284, 555-556.
43. zur Hausen H. (1996). Biochem. Biophys. Acta, 1288, F55- F78.
44. zur Hausen H and de Villiers EM. (1994). Ann. Rev. Microbiol., 48, 427-447.